RHÖN-KLINIKUM Aktiengesellschaft (LON:0NQH)
London
· Delayed Price · Currency is GBP · Price in EUR 14.80
-0.20 (-1.33%)
At close: Apr 24, 2025
LON:0NQH Revenue
In the year 2024, RHÖN-KLINIKUM Aktiengesellschaft had annual revenue of 1.87B EUR with 7.67% growth. RHÖN-KLINIKUM Aktiengesellschaft had revenue of 490.63M in the quarter ending December 31, 2024, with 7.10% growth.
Revenue
1.87B EUR
Revenue Growth
+7.67%
P/S Ratio
0.55
Revenue / Employee
132.78K EUR
Employees
14,067
Market Cap
857.24M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.87B | 133.13M | 7.67% |
| Dec 31, 2023 | 1.73B | 73.57M | 4.43% |
| Dec 31, 2022 | 1.66B | 69.95M | 4.40% |
| Dec 31, 2021 | 1.59B | 45.15M | 2.92% |
| Dec 31, 2020 | 1.55B | 65.12M | 4.40% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |